Clinical and hormonal outcome after two years of triiodothyroacetic acid treatment in a child with thyroid hormone resistance

Thyroid

Volumn 7, Issue 5, 1997, Pages 775-778

  Radetti, G ^a   Persani, L ^b   Molinaro, G ^a   Mannavola, D ^b   Cortelazzi, D ^b   Chatterjee, V K K ^c   Beck Peccoz, P ^b  

^a CENTRAL HOSPITAL OF BOLZANO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; LIOTHYRONINE; THYROGLOBULIN; THYROID HORMONE RECEPTOR; THYROTROPIN; THYROXINE; TIRATRICOL;

ARTICLE; CASE REPORT; CHILD; FAMILY STUDY; GENE MUTATION; HUMAN; HYPERTHYROIDISM; PRIORITY JOURNAL; RECEPTOR GENE; THYROID DISEASE; THYROID FUNCTION TEST; THYROID HORMONE RESISTANCE; TREATMENT OUTCOME;

EID: 0031406558     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1997.7.775     Document Type: Article

References (21)

1. Refetoff S, Weiss RE, Usala SJ 1993 The syndromes of resistance to thyroid hormones. Endocr Rev 14:348-399.
2. Chatterjee VKK, Beck-Peccoz P 1994 Thyroid hormone resistance. Ballière Clin Endocr Metab 8:267-283.
3. Refetoff S, De Wind LT, De Groot LJ. 1967 Familial syndrome combining deaf-mutism, stippled epiphyses, goiter and abnormal high PBI: Possible target organ refractoriness to thyroid hormone. J Clin Endocrinol Metab 27:279-294.
4. Gershengorn MC, Weintraub BD 1975 Thyrotropin-induced hyperthyroidism caused by selective pituitary resistance to thyroid hormone. A new syndrome of inappropriate secretion of TSH. J Clin Invest 56:633-642.
5. Beck-Peccoz P, Chatterjee VKK. 1994 The variable clinical phenotype in thyroid hormone resistance syndrome. Thyroid 4:225-231.
6. Beck-Peccoz P, Piscitelli G, Cattaneo MG, Faglia G. 1983 Successful treatment of hyperthyroidism due to nonneoplastic pituitary TSH hypersecretion with 3,5,3′-triiodothyroacetic acid (TRIAC). J Endocrinol Invest 6:217-223.
7. Takeda T, Suzuki S, Liu RT, DeGroot LJ 1995 Triiodothyroacetic acid has a unique potential for therapy of resistance to thyroid hormone. J Clin Endocrinol Metab 80:2033-2040.
8. Adams M, Matthews C, Collingwood TN, Tone Y, Beck-Peccoz P, Chatterjee VKK. 1994 Genetic analysis of 29 kindreds with generalized and pituitary resistance to thyroid hormone. Identification of thirteen novel mutations in the thyroid hormone receptor β gene. J Clin Invest 94:506-515.
9. Collingwood TN, Adams M, Tone Y, Chatterjee VKK 1994 Spectrum of transcriptional, dimerization, and dominant negative properties of twenty different mutant thyroid hormone beta-receptors in thyroid hormone resistance syndrome. Mol Endocrinol 8:1262-1277.
10. Persani L, Preziati D, Matthews CH, Sartorio A, Chatterjee VKK, Beck-Peccoz P 1997 Serum levels of carboxyterminal cross-linked telopeptide of type I collagen (ICTP) in the differential diagnosis of the syndromes of inappropriate secretion of TSH. Clin Endocrinol 47:207-214.
11. Beck-Peccoz P, Roncoroni R, Mariotti S, Medri G, Marcocci C, Brabant G, Forloni F, Pinchera A, Faglia G 1990 Sex hormone-binding globulin measurement in patients with inappropriate secretion of thyrotropin (IST): Evidence against selective pituitary thyroid hormone resistance in nonneoplastic IST. J Clin Endocrinol Metab 71:19-25.
12. Bodey B, Psenko V, Lipsey AL, Kaiser HE 1996 Soluble interleukin-2 receptors in sera of children with primary malignant neoplasms. Anticancer Res 16:219-224.
13. Mariotti S, Caturegli P, Barbesino G, Marinò M, Del Prete GF, Chiovato L, Tonacchera M, De Carli M, Pinchera A 1992 Thyroid function and thyroid autoimmunity independently modulate serum concentration of soluble interleukin 2 (IL2) receptor (sIL2R) in thyroid diseases. Clin Endocrinol 37:415-422.
14. Usala SJ, Tennyson GE, Bale AE, Lash RW, Gesundheit N, Wondisford FE, Accilli D, Hauser P, Weintraub BD 1990 A base mutation of the c-erbA beta thyroid hormone receptor in a kindred with generalized thyroid hormone resistance. Molecular heterogeneity in two other kindreds. J Clin Invest 85:93-100.
15. Takeda K, Weiss RE, Refetoff S. 1992 Rapid localization of mutations in the thyroid hormone receptor-β gene by denaturing gradient gel electrophoresis in 18 families with thyroid hormone resistance J Clin Endocrinol Metab 74:712-719.
16. [125]trioiodothyronine to fibroblast nuclei. J Endocrinol Invest 9:459-469.
17. Lazar MA. 1993 Thyroid hormone receptors: Multiple forms, multiple possibilities. Endocr Rev 14:184-193.
18. Falcone M, Miyamoto T, Fierro-Renoy F, Macchia E, DeGroot LJ 1992 Antipeptide polyclonal antibodies specifically recognize each human thyroid hormone receptor isoforms. Endocrinology 131:2419-2429.
19. Mixson AJ, Hauser P, Tennyson G, Renault JC, Bodenner DL, Weintraub BD 1993 Differential expression of mutant and normal beta T3 receptor alleles in kindreds with generalized resistance to thyroid hormone. J Clin Invest 91:2296-2300.
20. Persani L, Asteria C, Tonacchera M, Vitti P, Chatterjee VKK, Beck-Peccoz P 1994 Evidence for the secretion of thyrotropin with enhanced bioactivity in syndromes of thyroid hormone resistance. J Clin Endocrinol Metab 78:1034-1039.
21. Persani L, Cortelazzi D, Asteria C, Giammona E, Mannavola D, Beck-Peccoz P 1996 Modification of secretion, ricin lectin-binding and bioactivity of TSH from patients with resistance to thyroid hormone (RTH) treated with triiodothyroacetic acid (TRIAC) (Abs OR 40-1). Proceedings 10th International Congress of Endocrinology, San Francisco, CA, June 12-15, 1996, p. 121.